Luhadia S K
J Assoc Physicians India. 2014 Mar;62(3 Suppl):38-40.
Inspite of very safe and effective treatment, Bronchial asthmatics do not respond well in 5-10% of cases which are labelled as Refractory Asthma. Besides compliance, presence of psychogenic and trigger factors and comorbid illness, steroid insensitiveness or resistance may play a significant role in the poorly controlled/responding asthmatics. Type I Steroid resistance is due to lack of binding affinity of steroids to glucocorticoid receptors and may respond to higher doses of steroids while type II steroid resistance is because of reduced number of cells with glucocorticoid receptors, which is very rare and do not respond to even higher doses of systemic steroids and these cases require alternative/novel therapies. Future treatment of steroid resistant and severe refractory asthma is likely to be targeted towards cytokines and Bronchial Thermoplasty.
尽管有非常安全有效的治疗方法,但在5% - 10%被标记为难治性哮喘的病例中,支气管哮喘患者的治疗效果不佳。除了依从性、心理因素和触发因素以及合并症外,类固醇不敏感或抵抗可能在控制不佳/反应不良的哮喘患者中起重要作用。I型类固醇抵抗是由于类固醇与糖皮质激素受体缺乏结合亲和力,可能对更高剂量的类固醇有反应,而II型类固醇抵抗是由于具有糖皮质激素受体的细胞数量减少,这种情况非常罕见,甚至对更高剂量的全身类固醇也无反应,这些病例需要替代/新型疗法。类固醇抵抗和严重难治性哮喘的未来治疗可能针对细胞因子和支气管热成形术。